丹纳赫Q2业绩超预期任命新首席财务官

动脉网
22 Jul

生命科学公司丹纳赫在第二季度实现了超出预期的业绩,销售额达到59.4亿美元,同比增长3.5%,高于分析师预期的58.4亿美元。调整后每股收益为1.8美元,同比增长4.7%,同样超过预期的1.64美元。尽管生命科学部门和诊断部门增长放缓,但生物技术部门销售同比增长8%,弥补了这一不足。基于此,公司上调全年调整后每股收益预测至7.7至7.8美元之间,而此前预测为7.6至7.75美元,符合分析师预期。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10